At the Issue Date, the Company is authorized to issue an unlimited number of Ordinary shares of a no par value. As of the Issue Date hereof, the Company has reserved a total of 530,432 Ordinary shares under its 2017 Equity Incentive Plan, of which 0 shares are reserved for issuance upon exercise of outstanding options, and has assumed a total of 3,628,196 outstanding options pursuant to its assumption of the Borqs 2007 Global Share Plan. A true, correct and current copy of the Company’s Constitutional Documents, as proposed to be amended in connection with the consummation of the transactions outlined in the Merger Agreement (the “Merger”), is attached to the Proxy Statement filed with the U.S. Securities and Exchange Commission on July 14, 2017 (the “Proxy Statement”). Except as specified in the Proxy Statement, there are no other options, warrants, conversion privileges or other contractual rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of the Company or other securities.